Evidence map›Paper›PMID 24901457›Full record

ArticlePloS one2014

SOX2+ cell population from normal human brain white matter is able to generate mature oligodendrocytes.

Jorge Oliver-De La Cruz, Josefa Carrión-Navarro, Noemí García-Romero, Antonio Gutiérrez-Martín, Elisa Lázaro-Ibáñez, Carmen Escobedo-Lucea, Rosario Perona, Cristobal Belda-Iniesta, Angel Ayuso-Sacido

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Positive Controls in Adults and Children Support That Very Few, If Any, New Neurons Are Born in the Adult Human Hippocampus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Review
  5. Review
  6. Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jorge Oliver-De La CruzCentro Integral Oncológico Clara Campal (CIOCC) and Instituto de Medicina Molecular Aplicada (IMMA), Hospital de Madrid Foundation, Madrid, Spain.
Josefa Carrión-NavarroCentro Integral Oncológico Clara Campal (CIOCC) and Instituto de Medicina Molecular Aplicada (IMMA), Hospital de Madrid Foundation, Madrid, Spain.
Noemí García-RomeroNanomedicine Laboratory, Instituto Madrileño de Estudios Avanzados IMDEA nanoscience, Madrid, Spain.
Antonio Gutiérrez-MartínNeurosurgery Department, Hospital Universitario la Fe de Valencia, Valencia, Spain.
Elisa Lázaro-IbáñezCentro Integral Oncológico Clara Campal (CIOCC) and Instituto de Medicina Molecular Aplicada (IMMA), Hospital de Madrid Foundation, Madrid, Spain; Division of Biopharmaceuticals and Pharmacokinetics, University of Helsinki, Helsinki, Finland.
Carmen Escobedo-LuceaDivision of Biopharmaceuticals and Pharmacokinetics, University of Helsinki, Helsinki, Finland.
Rosario PeronaInstituto de Investigaciones Biomédicas CSIC/UAM, Madrid, Spain.
Cristobal Belda-IniestaCentro Integral Oncológico Clara Campal (CIOCC) and Instituto de Medicina Molecular Aplicada (IMMA), Hospital de Madrid Foundation, Madrid, Spain; Nanomedicine Laboratory, Instituto Madrileño de Estudios Avanzados IMDEA nanoscience, Madrid, Spain.
Angel Ayuso-SacidoCentro Integral Oncológico Clara Campal (CIOCC) and Instituto de Medicina Molecular Aplicada (IMMA), Hospital de Madrid Foundation, Madrid, Spain; Division of Biopharmaceuticals and Pharmacokinetics, University of Helsinki, Helsinki, Finland; Nanomedicine Laboratory, Instituto Madrileño de Estudios Avanzados IMDEA nanoscience, Madrid, Spain.
IMDEA Nanoscience · ESUniversity of Helsinki · FIUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesA number of neurodegenerative diseases progress with a loss of myelin, which makes them candidate diseases for the development of cell-replacement therapies based on mobilisation or isolation of the endogenous neural/glial progenitor cells, in vitro expansion, and further implantation. Cells expressing A2B5 or PDGFRA/CNP have been isolated within the pool of glial progenitor cells in the subcortical white matter of the normal adult human brain, all of which demonstrate glial progenitor features. However, the heterogeneity and differentiation potential of this pool of cells is not yet well established.

methodsWe used diffusion tensor images, histopathology, and immunostaining analysis to demonstrate normal cytoarchitecture and the absence of abnormalities in human temporal lobe samples from patients with mesial temporal sclerosis. These samples were used to isolate and enrich glial progenitor cells in vitro, and later to detect such cells in vivo.

resultsWe have identified a subpopulation of SOX2+ cells, most of them co-localising with OLIG2, in the white matter of the normal adult human brain in vivo. These cells can be isolated and enriched in vitro, where they proliferate and generate immature (O4+) and mature (MBP+) oligodendrocytes and, to a lesser extent, astrocytes (GFAP+).

conclusionOur results demonstrate the existence of a new glial progenitor cell subpopulation that expresses SOX2 in the white matter of the normal adult human brain. These cells might be of use for tissue regeneration procedures.

Indexed as

Basic Helix-Loop-Helix ProteinsBrainCell DifferentiationCells, CulturedDiffusion Tensor ImagingHumansImmunohistochemistryMyelin Basic ProteinNerve Tissue ProteinsNeural Stem CellsNeurogliaOligodendrocyte Transcription Factor 2OligodendrogliaSOXB1 Transcription FactorsStem CellsWhite MatterBasic Helix-Loop-Helix ProteinsMBP protein, humanMyelin Basic ProteinNerve Tissue ProteinsOLIG2 protein, humanOligodendrocyte Transcription Factor 2SOX2 protein, humanSOXB1 Transcription Factors

Identifiers

PMID24901457
PMCPMC4047120
OpenAlexW2082257347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.